The diagnostic performance of HN and MOTS-c gene expression, measured in whole blood and plasma, as well as the circulating plasma levels of these peptides, was insufficient for distinguishing AD from MCI and SCD patients considered together. Here, MT-RNR1 is linked to Alzheimer disease.